OTLKW
Outlook Therapeutics Inc
Halal Rating :
Last Price
$0.05
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Outlook Therapeutics Inc is a biopharmaceutical company focused on developing and commercializing ONS-5010, a proposed ophthalmic formulation of bevacizumab for various retinal indications. The company aims to address the significant unmet needs in the retina market with their innovative therapeutics.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Outlook Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.